Tapering of SSRI treatment to mitigate withdrawal symptoms

Affiliations

¹ Department of Psychiatry, Radboud University Medical Center, Nijmegen, Netherlands; Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, Netherlands; Dutch Association for Psychiatry, Utrecht, Netherlands. Electronic address: h.g.ruhe@gmail.com.
² Royal Dutch Pharmacists Association, The Hague, Netherlands.
³ Dutch College of General Practitioners, Utrecht, Netherlands.
⁴ MIND Landelijk Platform Psychische Gezondheid, Amersfoort, Netherlands.

Comment

Henricus G Ruhe et al. Lancet Psychiatry. 2019 Jul.

. 2019 Jul;6(7):561-562.

doi: 10.1016/S2215-0366(19)30182-8.

¹ Department of Psychiatry, Radboud University Medical Center, Nijmegen, Netherlands; Donders Institute for Brain, Cognition and Behavior, Radboud University, Nijmegen, Netherlands; Dutch Association for Psychiatry, Utrecht, Netherlands. Electronic address: h.g.ruhe@gmail.com.
² Royal Dutch Pharmacists Association, The Hague, Netherlands.
³ Dutch College of General Practitioners, Utrecht, Netherlands.
⁴ MIND Landelijk Platform Psychische Gezondheid, Amersfoort, Netherlands.

No abstract available

Comment in

Tapering of SSRI treatment to mitigate withdrawal symptoms - Authors' reply.
Horowitz MA, Taylor D. Horowitz MA, et al. Lancet Psychiatry. 2019 Jul;6(7):562-563. doi: 10.1016/S2215-0366(19)30219-6. Lancet Psychiatry. 2019. PMID: 31230678 No abstract available.

Tapering of SSRI treatment to mitigate withdrawal symptoms.
Horowitz MA, Taylor D. Horowitz MA, et al. Lancet Psychiatry. 2019 Jun;6(6):538-546. doi: 10.1016/S2215-0366(19)30032-X. Epub 2019 Mar 5. Lancet Psychiatry. 2019. PMID: 30850328 Review.